|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM,
Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dorigo O, et al:
Cervical cancer, version 2.2015. J Natl Compr Canc Netw.
13:395–404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Small W Jr, Bacon MA, Bajaj A, Chuang LT,
Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR,
Viswanathan AN and Gaffney DK: Cervical cancer: A global health
crisis. Cancer. 123:2404–2412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wentzensen N, Schiffman M, Palmer T and
Arbyn M: Triage of HPV positive women in cervical cancer screening.
J Clin Virol. 76 (Suppl 1):S49–S55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lowy DR: HPV vaccination to prevent
cervical cancer and other HPV-associated disease: From basic
science to effective interventions. J Clin Invest. 126:5–11. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Walboomers JM and Meijer CJ: Do
HPV-negative cervical carcinomas exist? J Pathol. 181:253–254.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cancer Genome Atlas Research Network;
Albert Einstein College of Medicine; Analytical Biological
Services; Barretos Cancer Hospital; Baylor College of Medicine;
Beckman Research Institute of City of Hope; Buck Institute for
Research on Aging; Canada's Michael Smith Genome Sciences Centre;
Harvard Medical School; Helen F. Graham Cancer Center &Research
Institute at Christiana Care Health Services, ; et al: Integrated
genomic and molecular characterization of cervical cancer. Nature.
543:378–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Swaffer MP, Jones AW, Flynn HR, Snijders
AP and Nurse P: CDK substrate phosphorylation and ordering the cell
cycle. Cell. 167:1750–1761.e16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen SN, Wang H and Gong BL: Expressions
of miRNA29 target genes CCND2 and CDK6 in cervical cancer. Disc
Clin Cases. 5:14–18. 2018. View Article : Google Scholar
|
|
10
|
Sherr CJ, Beach D and Shapiro GI:
Targeting CDK4 and CDK6: From discovery to therapy. Cancer Discov.
6:353–367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Guessous F, Zhang Y, Dipierro C,
Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen
TD, et al: MicroRNA-34a inhibits glioblastoma growth by targeting
multiple oncogenes. Cancer Res. 69:7569–7576. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao Y, Liu Y, Lin L, Huang Q, He W, Zhang
S, Dong S, Wen Z, Rao J, Liao W and Shi M: The lncRNA MACC1-AS1
promotes gastric cancer cell metabolic plasticity via AMPK/Lin28
mediated mRNA stability of MACC1. Mol Cancer. 17:692018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He W, Liang B, Wang C, Li S, Zhao Y, Huang
Q, Liu Z, Yao Z, Wu Q, Liao W, et al: MSC-regulated lncRNA
MACC1-AS1 promotes stemness and chemoresistance through fatty acid
oxidation in gastric cancer. Oncogene. 38:4637–4654. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Busch A, Richter AS and Backofen R:
IntaRNA: Efficient prediction of bacterial sRNA targets
incorporating target site accessibility and seed regions.
Bioinformatics. 24:2849–2856. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Strohl AE, Mendoza G, Ghant MS, Cameron
KA, Simon MA, Schink JC and Marsh EE: Barriers to prevention:
Knowledge of HPV, cervical cancer, and HPV vaccinations among
African American women. Am J Obstet Gynecol. 212:65 e1–e5. 2015.
View Article : Google Scholar
|
|
18
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing MiRNA- LncRNA Interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jalali S, Bhartiya D, Lalwani MK,
Sivasubbu S and Scaria V: Systematic transcriptome wide analysis of
lncRNA-miRNA interactions. PLoS One. 8:e538232013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu C, Kelnar K, Liu B, Chen X,
Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et
al: The microRNA miR-34a inhibits prostate cancer stem cells and
metastasis by directly repressing CD44. Nat Med. 17:211–215. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei JS, Song YK, Durinck S, Chen QR, Cheuk
AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J and Khan J: The
MYCN oncogene is a direct target of miR-34a. Oncogene.
27:5204–5213. 2008. View Article : Google Scholar : PubMed/NCBI
|
